Carter v. Mead Johnson & Company, LLC

CourtDistrict Court, N.D. Illinois
DecidedJuly 3, 2025
Docket1:24-cv-11760
StatusUnknown

This text of Carter v. Mead Johnson & Company, LLC (Carter v. Mead Johnson & Company, LLC) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Carter v. Mead Johnson & Company, LLC, (N.D. Ill. 2025).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

IN RE: ABBOTT LABORATORIES, ET AL. ) PRETERM INFANT NUTRITION PRODUCTS ) MDL No. 3026 LIABILITY LITIGATION ) _____________________________________ ) Master Docket No. 22 C 71 This Document Relates to: ) ) Drayton v. Abbott Laboratories, et al ) Nos. 24 C 11761 Taylor v. Abbott Laboratories, et al ) 24 C 11764 Wieger v. Abbott Laboratories, et al ) 24 C 11763 Abdullah v. Abbott Laboratories, et al ) 24 C 11759 Stills v. Abbott Laboratories, et al ) 24 C 11765 Carter v. Abbott Laboratories, et al ) 24 C 11760

MEMORANDUM OPINION AND ORDER Before the court are motions to remand six cases that were simultaneously removed from Pennsylvania state court. The claims involved are among hundreds against Defendants Mead Johnson & Company LLC, Mead Johnson Nutrition Company (collectively “Mead Johnson”), and Abbott Laboratories (“Abbott”), in which Plaintiffs have alleged that infant formula products manufactured by Defendants caused necrotizing enterocolitis (NEC) in pre-term infants. This is not Defendants’ first effort to remove these cases to federal court. In two prior rulings,1 this court ordered remand because these Plaintiffs had named, as defendants, the Pennsylvania hospital and hospital system (“hospital defendants”) where their infant children were fed with the formula products. The hospital defendants were not diverse from all the Plaintiffs (some, not all, were Pennsylvania citizens) and, moreover, were citizens of the forum-state, so their presence in the case barred removal. Defendant Abbott argued that the hospital defendants were fraudulently joined, but the court rejected the argument. Having now secured dismissals of the forum- defendants in state court, Abbott again seeks a federal forum. For the reasons explained below,

1 In re Abbott Lab’ys, No. 22 C 71, 2022 WL 3586150 (N.D. Ill. Aug. 22, 2022) (hereinafter “Abbott I”) and In re Abbott Lab’ys,. No. 22 C 71, 2022 WL 7501283 (N.D. Ill. Oct. 12, 2022) (hereinafter “Abbott II”). the court denies Plaintiffs’ motions for remand, but certifies its order for interlocutory appeal under 28 U.S.C. § 1292(b).

BACKGROUND Plaintiffs Shondera Drayton, Christina Taylor, Gina Wieger, Terraine Abdullah, Alice Stills, and Holli Carter (all represented by the same attorney) commenced their lawsuits against Defendants in Pennsylvania state court on March 24, 2022. (Drayton Notice of Removal [1] ¶¶ 1, 7; Taylor Notice of Removal [1] ¶¶ 1, 7; Wieger Notice of Removal [1] ¶¶ 1, 7; Abdullah Notice of Removal [1] ¶¶ 1, 7; Stills Notice of Removal [1] ¶¶ 1, 7; Carter Notice of Removal [1] ¶¶ 1, 7.) Each of the six Plaintiffs initially brought claims against Mead Johnson, Abbott, and the hospital defendants. See Abbott I at *2 (discussing the same claims). Abbott then removed the cases, along with 23 similar claims2 brought in Pennsylvania state court, to federal court under 28 U.S.C. § 1332, asserting that Abbott is diverse from the plaintiffs and that the amount in controversy is satisfied. See id. at *1. Plaintiffs moved for remand, noting the presence of the in-state hospital defendants—who were not diverse from many plaintiffs with Pennsylvania citizenship, and whose presence triggered the forum-defendant rule that bars removal on the basis of diversity from a defendant’s home state. Id. Abbott contended that the hospital defendants’ citizenship should be disregarded for the purposes of ascertaining jurisdiction because they were fraudulently joined. Id. This court considered and rejected Abbott’s fraudulent joinder arguments in two rulings. First, in Abbott I, this court rejected Abbott’s contention that Plaintiff’s theories of liability against the hospital defendants in negligence had “no reasonable possibility of success.” Abbott I at *8. In so finding, the court noted allegations that the hospitals had knowledge of the “increased risk of NEC and death” posed by the infant formulas and took no steps to mitigate the danger or warn

2 The court is not aware of the status of these additional cases as they have not, for now, been removed again to this court. the Plaintiffs. Id. In Abbott II, this court then rejected Abbott’s argument that Plaintiffs’ claims against the hospital defendants were procedurally barred for failure to obtain certificates of merit under Pennsylvania law. Abbott II at *1. Though Plaintiffs had not obtained certificates of merit before filing actions against the hospitals (as required by Pennsylvania Rule of Civil Procedure 1042.3), the deadline for obtaining a certificate of merit had not passed at the time of removal; the court concluded, therefore, that failure to obtain certificates of merit did not provide a basis for finding fraudulent joinder. Id. at *2–3. The court remanded the cases to Pennsylvania state court. Id. at *4. On October 21, 2024, the Pennsylvania Court of Common Pleas sustained Defendants’ preliminary objections3 against Plaintiffs’ claims against the hospital defendants, dismissing each Plaintiff’s claims against the hospital defendants with prejudice. (See Abdullah Notice of Removal, Ex. A-80 [1-5] at 632.)4 Judge Linda S. Carpenter wrote: This Court has reviewed the Complaint and taken as true the scant factual averments plead therein and agrees with the defendant hospital system that the claims plead by plaintiff against the hospital based on the facts alleged, are not recognized under Pennsylvania law and do not set forth a prima facie case under any recognized claim against the hospital system.

Id. In a phone call on October 30, 2024, the parties discussed Judge Carpenter’s dismissal of the claims against the hospitals. (Abdullah Richeson Decl. [14-6] ¶¶ 9–10.) During that call, Abbott’s counsel directly asked Plaintiffs’ counsel if they intended to appeal the dismissal, and Plaintiffs responded “No.” (Id. ¶ 10.) The next day, October 31, 2024, Abbott again removed all

3 Under Pennsylvania Rules of Civil Procedures, “preliminary objections,” not motions to dismiss, are the mechanism to seek dismissal of a complaint for failure to state a claim. See PA. R. CIV. P. 1028(4).

4 The Pennsylvania court issued separate orders for each of the cases discussed here, but the orders (attached to Abbott’s notices of removal) are identical and all reference the rationale set forth in the Abdullah ruling. six cases to federal court, noting that there was now full diversity between the parties,5 sufficient amounts in controversy, and no remaining forum-defendants in the case. (See Abdullah Notice of Removal ¶¶ 9, 11.) Mead Johnson consented to the removal. (Id. ¶ 7.) Then, on November 8, 2024, the Pennsylvania court appears to have amended its order dismissing the claims: the November 8 order granted Plaintiffs leave to amend their respective complaints regarding their corporate liability claims against the hospital defendants within 20 days. (See Abdullah Mot. to Remand, Ex. 8 [10-8] at 1–2.)6 Plaintiffs moved to remand promptly thereafter, on November 21, 2024.

DISCUSSION Under 28 U.S.C. § 1446(b)(3), a case that was not initially removable may be removed within 30 days of “an amended pleading, order, or other paper” that renders the case removable. In this case, though the presence of the in-state defendants made the case non-removable at the initial pleading stage, the Pennsylvania court’s dismissal of the hospital defendants removed that hurdle and triggered the possibility of removal. Removal pursuant to § 1446(b)(3) is cabined by two limitations, one statutory and one doctrinal.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

American Car & Foundry Co. v. Kettlehake
236 U.S. 311 (Supreme Court, 1915)
Caterpillar Inc. v. Lewis
519 U.S. 61 (Supreme Court, 1996)
Craig Garbie v. Daimler Chrysler Corp.
211 F.3d 407 (Seventh Circuit, 2000)
Schur v. L.A. Weight Loss Centers, Inc.
577 F.3d 752 (Seventh Circuit, 2009)
Cook v. Pep Boys-Mannie, Moe & Jack, Inc.
641 F. Supp. 43 (E.D. Pennsylvania, 1985)
Katonah v. USAir, Inc.
876 F. Supp. 984 (N.D. Illinois, 1995)
Abels v. State Farm Fire & Casualty Co.
694 F. Supp. 140 (W.D. Pennsylvania, 1988)
In Re Diet Drugs Products Liability Litigation
220 F. Supp. 2d 414 (E.D. Pennsylvania, 2002)
Feingold v. Hendrzak
15 A.3d 937 (Superior Court of Pennsylvania, 2011)
Faulk v. Husqvarna Consumer Outdoor Products N.A.
849 F. Supp. 2d 1327 (M.D. Alabama, 2012)
Katonah v. USAir, Inc.
868 F. Supp. 1031 (N.D. Illinois, 1994)

Cite This Page — Counsel Stack

Bluebook (online)
Carter v. Mead Johnson & Company, LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/carter-v-mead-johnson-company-llc-ilnd-2025.